Background: Previous studies suggested that Interleukin-10 (IL-10) depletion in Crohn's disease (CD) could predict outcome. Aim: To determine IL-10 in blood and at different intestinal locations in patients with active CD and to assess its potential prognostic capacity to identify aggressive CD. Methods: Twenty-three patients with CD were included. Ulcerative colitis (UC), infectious colitis and healthy individuals acted as controls. Serum and mucosal samples were taken at baseline and 1 month after steroid initiation in CD patients. Patients were classified according to steroid response. Control samples were obtained from different intestinal locations. IL-10 expression was measured with real-time polymerase chain reaction, immunofluorescence (intestine) and ELISA (serum, biopsy cultures' supernatants and tissue homogenates). Results: CD and UC showed an increase in IL-10 messenger RNA (mRNA) versus controls (p
CITATION STYLE
Carrasco, A., Tristán, E., Fernández-Bañares, F., Martín-Cardona, A., Aceituno, M., Zabana, Y., … Esteve, M. (2022). Mucosal Interleukin-10 depletion in steroid-refractory Crohn’s disease patients. Immunity, Inflammation and Disease, 10(10). https://doi.org/10.1002/iid3.710
Mendeley helps you to discover research relevant for your work.